Skip to main content

Main menu

  • Home
  • Issues
    • Issue in progress
    • Issues by date
  • Sections
    • Editorial
    • Review
    • Research
    • Commentary
    • Psychopharmacology for the Clinician
    • Letters to the Editor
  • Topic Collections
  • Instructions for authors
    • Overview for authors
    • Submission checklist
    • Editorial policies
    • Publication fees
    • Submit a manuscript
    • Dr. Francis Wayne Quan Memorial Prize
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • CJS
    • JAMC

User menu

Search

  • Advanced search
JPN
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • CJS
    • JAMC
JPN

Advanced Search

  • Home
  • Issues
    • Issue in progress
    • Issues by date
  • Sections
    • Editorial
    • Review
    • Research
    • Commentary
    • Psychopharmacology for the Clinician
    • Letters to the Editor
  • Topic Collections
  • Instructions for authors
    • Overview for authors
    • Submission checklist
    • Editorial policies
    • Publication fees
    • Submit a manuscript
    • Dr. Francis Wayne Quan Memorial Prize
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • Subscribe to our alerts
  • RSS feeds
  • Follow JPN on Twitter

More articles from research paper

  • You have access
    Does naltrexone treatment lead to depression? Findings from a randomized controlled trial in subjects with opioid dependence
    Angela J. Dean, John B. Saunders, Rod T. Jones, Ross M. Young, Jason P. Connor and Bruce R. Lawford
    J Psychiatry Neurosci January 01, 2006 31 (1) 38-45;
  • You have access
    Efficacy of methylphenidate in children with attention-deficit hyperactivity disorder and learning disabilities: a randomized crossover trial
    Natalie Grizenko, Mamatha Bhat, George Schwartz, Marina Ter-Stepanian and Ridha Joober
    J Psychiatry Neurosci January 01, 2006 31 (1) 46-51;
  • You have access
    Long-term lithium treatment and thyroid antibodies: a controlled study
    Christopher Baethge, Holger Blumentritt, Anne Berghöfer, Tom Bschor, Tasha Glenn, Mazda Adli, Peter Schlattmann, Michael Bauer and Reinhard Finke
    J Psychiatry Neurosci November 01, 2005 30 (6) 423-427;
  • You have access
    Proton magnetic resonance spectroscopy of the anterior cingulate gyrus, insular cortex and thalamus in schizophrenia associated with idiopathic unconjugated hyperbilirubinemia (Gilbert’s syndrome)
    Rei Yasukawa, Tsuyoshi Miyaoka, Shoichi Mizuno, Takuji Inagaki, Jun Horiguchi, Kazushige Oda and Hajime Kitagaki
    J Psychiatry Neurosci November 01, 2005 30 (6) 416-422;
  • You have access
    Evidence for the activity of lamotrigine at 5-HT1A receptors in the mouse forced swimming test
    Michel Bourin, Fabienne Masse and Martine Hascoët
    J Psychiatry Neurosci July 01, 2005 30 (4) 275-282;
  • You have access
    Responsiveness of 5-HT1A and 5-HT2 receptors in the rat orbitofrontal cortex after long-term serotonin reuptake inhibition
    Mostafa El Mansari and Pierre Blier
    J Psychiatry Neurosci July 01, 2005 30 (4) 268-274;
  • You have access
    Amitriptyline and fluoxetine protect PC12 cells from cell death induced by hydrogen peroxide
    Nathan Kolla, Zelan Wei, J. Steven Richardson and Xin-Min Li
    J Psychiatry Neurosci May 01, 2005 30 (3) 196-201;
  • You have access
    Loudness dependence of the auditory evoked potential and response to antidepressants in Chinese patients with major depression
    Tien-Wen Lee, Younger W.Y. Yu, Tai-Jui Chen and Shih-Jen Tsai
    J Psychiatry Neurosci May 01, 2005 30 (3) 202-205;
  • You have access
    Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study
    Bruno Gagnon, Graeme Low and Gil Schreier
    J Psychiatry Neurosci March 01, 2005 30 (2) 100-107;
  • You have access
    Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene
    Maryvonne Le Saux and Thérèse Di Paolo
    J Psychiatry Neurosci March 01, 2005 30 (2) 110-117;

Pages

  • Previous
  • Next
  • 1
  • …
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52

Content

  • Current issue
  • Past issues
  • Collections
  • Alerts
  • RSS

Authors & Reviewers

  • Overview for Authors
  • Submit a manuscript
  • Manuscript Submission Checklist

About

  • General Information
  • Staff
  • Editorial Board
  • Contact Us
  • Advertising
  • Reprints
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1180-4882.

All editorial matter in JPN represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.
To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected].

CMA Civility, Accessibility, Privacy

 

Powered by HighWire